Hancock Whitney Corp Eli Lilly & CO Transaction History

Hancock Whitney Corp

  • $3.07 Billion
  • Q3 2024

A detailed history of Hancock Whitney Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Hancock Whitney Corp holds 41,691 shares of LLY stock, worth $32.7 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
41,691
Previous 41,484 0.5%
Holding current value
$32.7 Million
Previous $37.6 Million 1.66%
% of portfolio
1.2%
Previous 1.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$772.14 - $960.02 $159,832 - $198,724
207 Added 0.5%
41,691 $36.9 Million
Q2 2024

Aug 13, 2024
BUY
$724.87 - $909.04 $4.34 Million - $5.44 Million
5,982 Added 16.85%
41,484 $37.6 Million
Q1 2024

May 16, 2024
SELL
$592.2 - $792.28 $65,142 - $87,150
-110 Reduced 0.31%
35,502 $27.6 Million
Q4 2023

Feb 14, 2024
BUY
$525.19 - $619.13 $3.24 Million - $3.82 Million
6,174 Added 20.97%
35,612 $20.8 Million
Q3 2023

Nov 13, 2023
SELL
$434.7 - $599.3 $107,805 - $148,626
-248 Reduced 0.84%
29,438 $15.8 Million
Q2 2023

Nov 13, 2023
BUY
$350.74 - $468.98 $4.44 Million - $5.94 Million
12,667 Added 74.43%
29,686 $13.9 Million
Q2 2023

Aug 10, 2023
BUY
$350.74 - $468.98 $4.44 Million - $5.94 Million
12,667 Added 74.43%
29,686 $13.9 Million
Q1 2023

Nov 13, 2023
SELL
$310.63 - $364.82 $428,358 - $503,086
-1,379 Reduced 7.5%
17,019 $5.84 Million
Q1 2023

May 16, 2023
SELL
$310.63 - $364.82 $428,358 - $503,086
-1,379 Reduced 7.5%
17,019 $5.85 Million
Q4 2022

Nov 13, 2023
SELL
$321.55 - $374.67 $3.63 Million - $4.23 Million
-11,288 Reduced 38.02%
18,398 $6.73 Million
Q4 2022

Feb 03, 2023
SELL
$321.55 - $374.67 $45,660 - $53,203
-142 Reduced 0.77%
18,398 $6.73 Million
Q3 2022

Oct 26, 2022
SELL
$296.48 - $337.87 $155,059 - $176,706
-523 Reduced 2.74%
18,540 $6 Million
Q2 2022

Aug 08, 2022
SELL
$278.73 - $327.27 $120,690 - $141,707
-433 Reduced 2.22%
19,063 $6.18 Million
Q1 2022

May 12, 2022
SELL
$234.69 - $291.66 $149,028 - $185,204
-635 Reduced 3.15%
19,496 $5.58 Million
Q4 2021

Jan 25, 2022
BUY
$224.85 - $279.04 $33,727 - $41,856
150 Added 0.75%
20,131 $5.56 Million
Q3 2021

Nov 04, 2021
BUY
$221.6 - $272.71 $996,092 - $1.23 Million
4,495 Added 29.03%
19,981 $4.62 Million
Q2 2021

Aug 09, 2021
BUY
$180.55 - $233.54 $39,179 - $50,678
217 Added 1.42%
15,486 $3.55 Million
Q1 2021

May 14, 2021
SELL
$164.32 - $212.72 $383,851 - $496,913
-2,336 Reduced 13.27%
15,269 $2.85 Million
Q4 2020

Feb 09, 2021
SELL
$130.46 - $172.63 $33,528 - $44,365
-257 Reduced 1.44%
17,605 $2.97 Million
Q3 2020

Nov 05, 2020
SELL
$146.22 - $169.13 $43,427 - $50,231
-297 Reduced 1.64%
17,862 $2.64 Million
Q2 2020

Jul 30, 2020
SELL
$136.42 - $164.18 $1.97 Million - $2.37 Million
-14,437 Reduced 44.29%
18,159 $2.98 Million
Q1 2020

May 08, 2020
BUY
$119.05 - $147.35 $631,798 - $781,986
5,307 Added 19.45%
32,596 $4.52 Million
Q4 2019

Feb 06, 2020
SELL
$106.92 - $132.43 $287,294 - $355,839
-2,687 Reduced 8.96%
27,289 $3.59 Million
Q3 2019

Oct 29, 2019
SELL
$106.79 - $116.16 $221,268 - $240,683
-2,072 Reduced 6.47%
29,976 $3.35 Million
Q2 2019

Aug 29, 2019
BUY
$110.79 - $129.32 $25,814 - $30,131
233 Added 0.73%
32,048 $3.55 Million
Q1 2019

May 13, 2019
BUY
$111.31 - $131.02 $143,923 - $169,408
1,293 Added 4.24%
31,815 $4.13 Million
Q4 2018

Feb 15, 2019
BUY
$105.9 - $118.64 $471,255 - $527,948
4,450 Added 17.07%
30,522 $3.53 Million
Q3 2018

Nov 14, 2018
BUY
$85.86 - $107.31 $2.24 Million - $2.8 Million
26,072 New
26,072 $2.8 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email